Business Context and Reporting Period
Company: Entegris, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 27, 2009
Industry: Semiconductor and high-technology materials (purification, protection, and transport of critical materials).
Context: The Company is navigating a severe downturn in the semiconductor industry that began in late 2008. While unit-driven consumable products saw a modest sequential recovery in Q2 2009, capital-driven product lines remain soft. The Company amended its credit facility in March 2009 to avoid covenant violations and is implementing significant cost-reduction measures.
Key Financial Metrics
| Metric (in thousands) | Q2 2009 (3 Months) | Q2 2008 (3 Months) | YTD 2009 (6 Months) | YTD 2008 (6 Months) |
|---|---|---|---|---|
| Net Sales | $82,576 | $147,947 | $141,614 | $296,174 |
| Gross Profit | $23,730 | $59,887 | $28,748 | $123,875 |
| Gross Margin % | 28.7% | 40.5% | 20.3% | 41.8% |
| Operating (Loss) Income | $(20,181) | $7,868 | $(63,403) | $12,946 |
| Net (Loss) Income | $(22,492) | $4,933 | $(60,237) | $7,798 |
| Diluted EPS (Loss) | $(0.20) | $0.04 | $(0.54) | $0.07 |
| Cash and Equivalents (End of Period) | $84,066 | $132,408 | $84,066 | $132,408 |
| Total Debt (Current + Long-term) | $151,667 | $163,682 | $151,667 | $163,682 |
| Working Capital | $161,437 | $233,772 | $161,437 | $233,772 |
Note: Debt figures derived from Balance Sheet (Current maturities of long-term debt + Short-term borrowings + Long-term debt less current maturities).
Material Changes vs. Prior Period
- Revenue Decline: Q2 2009 net sales fell 44% year-over-year (YoY) to $82.6 million. Excluding the POCO Graphite acquisition, sales fell 50%. YTD sales declined 52% YoY.
- Margin Compression: Gross margin dropped from 40.5% in Q2 2008 to 28.7% in Q2 2009 due to significantly lower factory utilization and fixed cost absorption issues. The Company recorded $2.1 million in below-capacity production charges in Q2.
- Restructuring Charges: The Company incurred $5.5 million in restructuring charges in Q2 2009 (totaling $10.1 million YTD) related to workforce reductions and facility closures, compared to none in the prior year periods.
- Segment Performance:
- Contamination Control Solutions (CCS): Sales down 46% YoY; Segment profit turned to a loss YTD ($5.1M loss vs $47.1M profit).
- Micro Environments (ME): Sales down 55% YoY; Segment loss of $10.2M YTD vs $17.4M profit.
- Entegris Specialty Materials (ESM): Sales up 344% YoY primarily due to the POCO acquisition; however, excluding POCO, sales fell 62%.
- Cash Flow: Operating activities used $6.3 million in cash YTD 2009, compared to providing $30.0 million in YTD 2008.
Guidance, Outlook, Risks, and Contingencies
- Debt Covenants: The Company amended its revolving credit facility to $150 million in March 2009. It is currently in compliance but faces strict EBITDA covenants for 2009 and 2010. Management warns that if revenue levels do not improve, further contingency actions (furloughs, headcount reductions, office closures) may be required to avoid covenant violations.
- Liquidity: Cash and cash equivalents were $84.1 million at period end. The Company has $129.5 million outstanding on its credit facility, with a borrowing cap of approximately $131.1 million (subject to step-downs). Management believes current liquidity is sufficient for the next 12 months but notes uncertainty in obtaining additional financing due to credit market conditions.
- Outlook: Management expects the upturn in unit-driven consumable products to continue through 2009 but does not forecast increased volume for capital-driven product lines. No convincing indications of economic recovery in capital-driven lines have been discernible.
- Legal Proceedings: Ongoing patent litigation with Pall Corporation regarding fluid separation systems and filtration products. The Company intends to vigorously defend these suits.
- Valuation Allowance: The Company increased its U.S. deferred tax asset valuation allowance by $14.8 million, concluding it is not more likely than not that these assets will be realized due to cumulative operating losses.
Investor Verification Checklist
- Covenant Compliance: Verify the Company's ability to meet the negative EBITDA thresholds required by the amended credit agreement for the remainder of 2009.
- Revenue Recovery: Monitor sequential sales trends to determine if the modest Q2 recovery in unit-driven products is sustainable or if capital-driven spending remains depressed.
- Cost Reduction Execution: Assess the impact of announced restructuring charges and workforce reductions on future operating expenses and SG&A.
- Inventory Levels: Review inventory write-downs and obsolescence provisions, as the Company holds significant inventory relative to current sales volumes.
- Legal Exposure: Track the status of patent litigation with Pall Corporation, which could result in damages or injunctions affecting product sales.